The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: 0.00 (0.00%)
Spread: 2.00 (0.017%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 12,050.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

WRAPUP 3-'The beginning of the end': Europe rolls out vaccines to fight pandemic

Sun, 27th Dec 2020 10:17

(Adds quotes from Macron, Greece, Norway, detail and background
on new variants, German glitches)

* Goal is to offer vaccine to all adults through 2021

* EU has secured contracts for 2 billion-plus doses

* Frontline workers and elderly among those prioritised

* 'Thank God,' says first recipient in Spain, 96

By Isla Binnie and Giselda Vagnoni

MADRID/ROME, Dec 27 (Reuters) - Europe launched a mass
COVID-19 vaccination drive on Sunday with pensioners and medics
lining up to get the first shots to see off a pandemic that has
crippled economies and claimed more than 1.7 million lives
worldwide.

"Thank God," 96-year-old Araceli Hidalgo said as she became
the first person in Spain to have a vaccine at her care home in
Guadalajara near the capital Madrid. "Let's see if we can make
this virus go away."

In Italy, the first country in Europe to record significant
numbers of infections, 29-year-old nurse Claudia Alivernini was
one of three medical staff at the head of the queue for the shot
developed by Pfizer and BioNTech.

"It is the beginning of the end ... it was an exciting,
historic moment," she said at Rome's Spallanzani hospital.

The region of 450 million people is trying to catch up with
the United States and Britain which have both already started
vaccinations using the Pfizer/BioNTech shot.

The EU is due to receive 12.5 million doses of the shot by
the end of the year, enough to vaccinate 6.25 million people
based on the two-dose regimen. The companies are scrambling to
meet global demand and aim to make 1.3 billion shots next year.

Europe has secured contracts with a range of drugmakers
besides Pfizer including Moderna and AstraZeneca
, for a total of more than two billion vaccine doses and
has set a goal for all adults to be inoculated during 2021.

While Europe has some of the best-resourced healthcare
systems in the world, the sheer scale of the effort means some
countries are calling on retired medics to help while others
have loosened rules for who is allowed to give the injections.

With surveys pointing to high levels of hesitancy towards
the vaccine in countries from France to Poland, leaders of the
27-country European Union are promoting it as the best chance of
getting back to something like normal life next year.

"We have a new weapon against the virus: the vaccine. We
must stand firm, once more," tweeted French President Emmanuel
Macron, who tested positive for the coronavirus this month and
left quarantine on Christmas Eve.

SOLAR-POWERED PAVILIONS

After European governments were criticised for failing to
work together to counter the spread of the virus in early 2020,
the goal this time is to ensure that there is equal access to
the vaccines across the region.

But even then, Hungary on Saturday jumped the gun on the
official roll-out by administering shots to frontline workers at
hospitals in the capital Budapest.

Slovakia also went ahead with some inoculations of
healthcare staff on Saturday and in Germany, a small number of
people at a care home were inoculated a day early too.

"We don't want to waste that one day that the vaccine loses
shelf life," Karsten Fischer, from the pandemic staff of the
Harz district in the German state of Saxony-Anhalt, told local
broadcaster MDR.

The distribution of the shot presents tough challenges as
the vaccine uses new mRNA technology and must be stored at
ultra-low temperatures of about -70 degrees Celsius (-112°F).

In Germany, several vaccination centres in Northern Bavaria
held off from inoculating people after uncertainty arose on
whether the cold chain had been maintained.
"When reading the temperature loggers that were enclosed in
the cool boxes, doubts arose about the compliance with the cold
chain requirements", the vaccination centres of Coburg,
Lichtenfels, Kronach, Kulmbach, Hof, Bayreuth and Wunsiedel said
in a joint statement.
The Pfizer shots being used in Europe were shipped from its
factory in Puurs, Belgium, in specially designed containers
filled with dry ice. They can be stored for up to six months at
Antarctic winter temperatures, or for five days at 2C to 8C, a
type of refrigeration commonly available at hospitals.

Beyond hospitals and care homes, sports halls and convention
centres left vacant by lockdown restrictions will become venues
for mass inoculations.

In Italy, temporary solar-powered healthcare pavilions
designed to look like five-petalled primrose flowers - a symbol
of spring - sprouted in town squares.

NEW VARIANT

At the Santa Maria hospital in Portugal's capital Lisbon,
Pedro Pires waited for a shot with other nurses at the end of a
10-hour overnight shift. "It has been tiring ... a lot of work,"
he told Reuters.

Branka Anicic, 81, a resident of a care home in Zagreb and
became the first person to get a shot in Croatia. "I'm happy I
will now be able to see my great-grandchildren," she said.

Vaccinations also started in Norway, which is not a member
of the bloc but part of the EU's drive.

"I feel like a historical figure ... almost like the first
man on the Moon," said care home resident Svein Andersen, 67, as
he received the country's first shot in the capital Oslo.

Some other European countries outside the EU, such as
Britain, Switzerland and Serbia, have already started
vaccinating their citizens with the Pfizer jab in recent weeks.

The vaccination drive is all the more urgent because of the
concern around new variants of the virus linked to a rapid
expansion of cases in Britain and South Africa.

"We know that the pandemic won't just disappear as of today,
but the vaccine is the beginning of the victory over the
pandemic, the vaccine is a 'game changer'. We have always know
that, and today is the first day of this new phase," Austrian
Chancellor Sebastian Kurz.

Over the past week, cases of the UK variant have been
detected in Australia, Hong Kong and in several European
countries, mostly recently Sweden and France. So far, scientists
say there is no evidence to suggest the vaccines developed will
be any less effective against them.

In Spain, doses were delivered by air to its island
territories and the North African enclaves of Ceuta and Melilla.

"Today is the first day of the countdown to getting our
lives back," said Vassilis Kikilias, the health minister of
Greece where the roll-out was a more ceremonial affair. The
president, the premier, the military chief and a bishop were all
due to get shots on Sunday.

"We are at war, but our weapon has arrived and it is in
these small vials," the head of Bulgaria's anti-virus taskforce,
General Ventsislav Mutafchiiski said after getting his
vaccination in Sofia.

(Additional reporting by Catarina Demony in Lisbon, Silke
Koltrowitz in Vienna, Robert Muller in Prague, Tsvetelia Tsolova
in Sofia, Igor Ilic in Zagreb, Nerijus Adomaitis in oslo,
Michele Kambas in Athens and Benoit Van Overstraeten in Paris;
Writing by Mark John and Andrew Heavens; Editing by David
Clarke)

More News
2 Jan 2024 12:01

LONDON MARKET MIDDAY: London stocks make largely soft start to 2024

(Alliance News) - Stock prices in London were mostly lower at midday on Tuesday in a slow start to the new year, reacting to the UK manufacturing sector finishing a tricky 2023 with a further contraction in December.

Read more
2 Jan 2024 11:00

Weight-loss drugs: Who, and what, are they good for?

Jan 2 (Reuters) - Powerful weight-loss medicines like Novo Nordisk's Wegovy leapt into public view in 2023, from social media to doctors' offices and cocktail parties, offering a new way to address record obesity rates.

Read more
2 Jan 2024 11:00

What other health conditions might weight-loss drugs treat?

Jan 2 (Reuters) - Novo Nordisk's blockbuster diabetes drug Ozempic and weight-loss therapy Wegovy are being studied to see whether they can improve health in other ways.

Read more
2 Jan 2024 08:48

LONDON MARKET OPEN: New Year begins largely green amid slew of PMIs

(Alliance News) - Stock prices in London opened mostly up on Tuesday, the first day of trading in 2024, reacting to slightly improved factory activity in China, with more manufacturing PMIs from major economies due.

Read more
2 Jan 2024 08:26

AstraZeneca and Sanofi received approval in China for RSV antibody

(Alliance News) - AstraZeneca PLC and Sanofi SA's long-acting monoclonal antibody Beyfortus received approval for use in China to prevent respiratory syncytial virus disease, Astra said on Tuesday.

Read more
2 Jan 2024 07:57

LONDON BRIEFING: AstraZeneca, Sanofi's RSV treatment approved in China

(Alliance News) - Stock prices in London are expected to open higher on Tuesday, reacting to a slight expansion in manufacturing activity in China and ahead of a slew of manufacturing PMI data including for the UK.

Read more
27 Dec 2023 17:04

Rate-cut optimism, autos push UK stocks higher

FTSE 100 up 0.4%, FTSE 250 adds 0.5%

*

Read more
27 Dec 2023 17:02

LONDON MARKET CLOSE: Stocks start week higher as 2024 draws to close

(Alliance News) - Equities in London kicked off an abbreviated trading week with gains on Wednesday, on continued US interest rate optimism at the end of 2024.

Read more
27 Dec 2023 14:25

London close: Stocks maintain gains amid post-Christmas rally

(Sharecast News) - London's stock markets closed in positive territory on Wednesday, buoyed by a global surge in stock prices as the S&P 500 neared an all-time high on Wall Street.

Read more
27 Dec 2023 12:06

LONDON MARKET MIDDAY: Stocks hold onto gains amid US rate cut hopes

(Alliance News) - London's FTSE 100 index was outperforming other European stock-price measures at midday on Wednesday, boosted by gains for miners and industrials.

Read more
27 Dec 2023 11:20

London midday: Stocks ride global wave of post-Christmas optimism

(Sharecast News) - London's equity markets were still above the waterline at lunchtime on Wednesday, following a late Santa rally on Wall Street overnight.

Read more
27 Dec 2023 08:48

LONDON MARKET OPEN: FTSE 100 gains led by miners and industrials

(Alliance News) - Stock prices in London opened in the green on Wednesday, as hopes for US interest rate cuts in the new year continued to propel global equities higher.

Read more
27 Dec 2023 08:26

London open: FTSE takes cues from Wall Street 'Santa rally'

(Sharecast News) - London's stocks returned from the Christmas break in the green on Wednesday, boosted by a late Santa rally on Wall Street overnight.

Read more
27 Dec 2023 08:24

TOP NEWS: AstraZeneca buys Gracell to "enrich" cell therapy pipeline

(Alliance News) - AstraZeneca PLC on Tuesday said it has agreed to acquire Gracell Biotechnologies Inc, paying about USD1.2 billion for the clinical-stage company.

Read more
27 Dec 2023 07:52

LONDON BRIEFING: AstraZeneca buys Gracell Biotech; COPL CEO resigns

(Alliance News) - Stocks in London were expected to make gains at Wednesday's market open, as investors continued to pin their hopes on US interest rate cuts.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.